We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.49 | 0.62% | 79.74 | 79.85 | 78.95 | 79.42 | 5,023,165 | 01:00:00 |
(FROM THE WALL STREET JOURNAL 12/8/14) By Sarah Krouse
Low interest rates and a resurgence in mergers and acquisitions this year, particularly big-ticket deals, have companies turning to the bond market like never before.
Boosted by medical-device maker Medtronic Inc.'s $17 billion corporate-debt sale last week, companies have issued $206.4 billion in bonds to fund acquisitions through Dec. 5, according to Dealogic. That is up nearly 30% from the same period last year and the highest level ever.
Medtronic's bond deal, which will be used to help finance its $43 billion purchase of Ireland-based Covidien PLC, is the largest corporate-bond offering this year.
The average size of U.S.-dollar investment-grade bond sales this year stands at $996 million, according to Dealogic, the highest since 2009, when the average deal size was $1 billion.
So far this year global corporate-bond deal volume, excluding financial institutions, stands at $2.17 trillion, a record year to date. In addition to Medtronic's deal, Apple Inc. sold $12 billion of investment-grade debt in April.
Access Investor Kit for Medtronic, Inc.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US5850551061
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions